Berger Montague Investigates Hims & Hers Health Board for Breach of Fiduciary Duty
Law firm Berger Montague PC announces an investigation into the Board of Directors of Hims & Hers Health, Inc. (NYSE: HIMS) for potential breaches of fiduciary duties.
National plaintiffs' law firm Berger Montague PC has announced an investigation into the Board of Directors of Hims & Hers Health, Inc. (NYSE: HIMS). The probe focuses on potential breaches of fiduciary duties owed to the company and its shareholders.
The investigation specifically examines the actions and decisions made by the company's board. Berger Montague is seeking information from any Hims & Hers shareholders who have relevant knowledge or experiences concerning potential misconduct.
The law firm aims to determine whether the directors have fulfilled their legal and corporate obligations to act in the best interests of the company and its stakeholders. This review is part of ongoing scrutiny of corporate governance practices within the health technology sector.
Hims & Hers Health operates a telehealth platform offering virtual consultations and prescription medication delivery services.